 |
|
|
 |
| (as at 31 December 2008) |
| |
|
| Consolidated Balance Sheets |
2008 |
2007 |
| |
RM'000 |
RM'000 |
| |
|
|
| Total non-current assets |
|
721,185 |
| Total current assets |
|
764,572 |
| Total assets |
2,123,054 |
1,485,757 |
| |
|
|
| Financed by : |
|
|
| Share capital |
402,849 |
402,563 |
| Reserves |
30,046 |
33,517 |
| Retained profits |
314,621 |
302,476 |
| Total equity attributable to equity holders
of the company |
747,516 |
738,556 |
| Minority interests |
111,075 |
99,856 |
| Total equity |
858,591 |
838,412 |
| Total non-current liabilities |
220,588 |
309,605 |
| Total current liabilities |
1,043,875 |
337,740 |
| Total liabilities |
1,264,463 |
647,345 |
| Total equity and liabilities |
2,123,054 |
1,485,757 |
| |
|
|
| Consolidated Income Statements |
2008 |
2007 |
| |
RM'000 |
RM'000 |
| |
|
|
| Turnover |
2,165,459 |
1,397,268 |
| |
|
|
| Profit before taxation |
120,268 |
105,551 |
| Taxation |
(34,767) |
(21,952) |
| Profit after taxation |
85,501 |
83,599 |
| Minority interests |
(20,475) |
(20,881) |
| Profit attributable to shareholders |
65,026 |
62,718 |
| |
|
|
| Group Financial Ratios |
2008 |
2007 |
| |
|
|
| Profitability (%) |
|
|
| Turnover growth rate |
54.98 |
25.87 |
| Profit before taxation as a % of turnover |
5.55 |
7.55 |
| Profit before taxation as a % of shareholders' funds |
16.09 |
14.29 |
| |
|
|
| Liquidity (%) |
|
|
| Current ratio |
1.23 |
2.26 |
| Acid test ratio |
0.73 |
1.56 |
| |
|
|
| Market Ratios (%) |
|
|
| Net assets per share |
1.86 |
1.83 |
| Earnings per share |
16.1 |
15.7 |
| Net dividend per share |
12.1 |
11.8 |
| |
|
|
| Productivity |
|
|
| Turnover per employee (RM) |
1,145 |
825 |
| Total Assets per employee (RM) |
1,123 |
877 |
| Number of employees |
1,891 |
1,693 |
| |
|
|
| |
|
|
| # Based on Duopharma’s full-year results consolidation |
|
 |
 |
 |
|
| |
|
